Chemotherapy and surgery for operable NSCLC

Lancet

Volumn 369, Issue 9577, 2007, Pages 1903-1904

  Bradbury, Penelope A ^a   Shepherd, Frances A ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; GEMCITABINE; NAVELBINE; PACLITAXEL; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG TOLERANCE; HEALTH CARE PLANNING; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; META ANALYSIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; PATIENT COMPLIANCE; PHYSICIAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 34250009786     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60715-6     Document Type: Note

References (13)

1. Alam N., Shepherd F., Winton T., et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer: an analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer 47 (2005) 385-394
2. Roth J., Fossella F., Komaki R., et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Natl Cancer Inst 86 (1994) 673-680
3. Rosell R., Gomez-Codina J., Camps C., et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer. N Engl J Med 330 (1994) 153-158
4. Gilligan D., Nicolson M., Smith I., et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet (2007). published online June 1. DOI:10.1016/S0140-6736(07)60714-4
5. Pisters K., Vallieres E., Bunn P., et al. S9900: a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC) preliminary results. J Clin Oncol 23 suppl 16 (2005) 624s (abstr LBA7012).
6. Winton T., Livingston R., Johnson D., et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352 (2005) 2589-2597
7. Douillard J., Rosell R., De Lena M., et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7 (2006) 719-727
8. Strauss G., Herndon J., Maddaus M., and for the CALGB RTOG. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633. J Clin Oncol 24 suppl 18 (2006) 365s (abstr 7007).
9. Pignon J., Tribodet H., Scagliotti G., and on behalf of the LACE Collaborative Group. Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 24 suppl 18 (2006) 366s (abstr 7008).
10. Depierre A., Milleron B., Moro-Sibilot D., et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2002) 247-253
11. Albain K., Scott C., Rusch V., for RTOG, SWOG, NCIC, ECOG, CALGB, and NCCTG. Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): initial results from intergroup trial 0139 (RTOG 93-09). Proc Am Soc Clin Oncol 22 (2003) 621 (abstr 2497).
12. Arriagada R., Bergman B., Dunant A., Chevalier T., Pignon J., and Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350 (2004) 351-360
13. Aljubran A., Leighl N., Pintilie M., Feld R., Burkes R., and Shepherd F. Compliance of adjuvant chemotherapy in non-small cell lung cancer (NSCLC); no longer an issue. J Clin Oncol 24 suppl 18 (2006) 402s (abstr 7154).